Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Read-Out Ready Platform Improves Lab Procedures

By LabMedica International staff writers
Posted on 21 Aug 2012
One-step collection, transport, incubation, and observation devices offer a simple solution for point-of-care (POC) infectious disease diagnosis.

The InTray and InPouch devices combine sample collection, transport, and culture in a single read-out ready platform, thereby reducing handling, increasing productivity, improving throughput, and reducing the risk of sample exposure and contamination. More...


The InPouch product is an easy-to-use, fully enclosed oxygen-resistant plastic pouch for microbiology sample collection, transport, culture, and observation. Once the sample has been inoculated, the InPouch is sealed against contamination. The optically clear InPouch can be directly viewed under the microscope without the need to prepare a wet mount slide. InPouch offers a variety of media that deliver specificity and selectivity and it has a shelf life of up to one year. InPouch is also compatible for use with polymerase chain reaction (PCR).

The InTray product is a fully enclosed cassette for microbiology sample collection, transport, and culture. This stackable device can be observed under a microscope through optically clear plastic, eliminating the need to prepare a wet mount slide. The fully enclosed system features controlled air exchange to protect against exposure or contamination, and is ideal for field use or austere environments. InTray products featuring Colorex technology produce easy-to-interpret results that can be read visually via color changes in the sample.

BioMed Diagnostics, Inc., (White City, OR, USA), the manufacturer of these microbiology devices, announced that its InTray and InPouch product lines will now be available worldwide through a new agreement with VWR International (Radnor, PA, USA) a global laboratory supply and distribution company. Under the terms of the agreement, VWR will distribute BioMed’s products for the diagnosis of infectious disease.

Steve Goodman, senior vice president of category management for VWR said, “The initial response to these products has been excellent and we look forward to making them available globally to the many labs and facilities that can benefit from their use.”

Related Links:
BioMed Diagnostics, Inc.
VWR International



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated MALDI-TOF MS System
EXS 3000
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.